Skip navigation
Skip navigation

Individualisation of antiviral therapy for chronic hepatitis C

Teoh, Narcissus; Farrell, Geoffrey; Chan, Henry L. Y.


The combination of pegylated-interferon (PEG-IFN)/ribavirin is currently the standard of care antiviral treatment for chronic hepatitis C (CHC), but optimal results require an individual approach. Key issues are to deliver doses that confer optimal antiviral efficacy against hepatitis C virus (HCV) for a time sufficient to minimise relapse. Viral monitoring during therapy guides the subsequent treatment course, particularly HCV RNA results at 4 weeks (rapid viral response [RVR]) and 12 weeks...[Show more]

CollectionsANU Research Publications
Date published: 2010
Type: Journal article
Source: Journal of Gastroenterology and Hepatology
DOI: 10.1111/j.1440-1746.2010.06392.x


File Description SizeFormat Image
01_Teoh_Individualisation_of_antiviral_2010.pdf293.37 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  20 July 2017/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator